Taxotere Off-Label Claims Not Time-Barred, Aren’t Free Speech, Judge Says

Mealey's (January 18, 2017, 1:04 PM EST) -- PHILADELPHIA — A False Claims Act lawsuit alleging off-label marketing of the chemotherapy drug Taxotere is not barred by the statute of limitations and is not aimed at “truthful, non-misleading” speech about off-label uses, a Pennsylvania federal judge said Jan. 9 in denying a new motion by defendant Aventis Inc. dismiss the 14-year-old case (United States of America, ex rel. Yoash Gohil v. Aventis, Inc., et al., No. 02-2964, E.D. Pa.)....

Attached Documents

Related Sections